Retina Vitreous Associates Medical Group

Recent papers from Retina Vitreous Associates Medical Group

1. Choroidal Folds and Hypotony Following Dexamethasone Intravitreal Implant InjectionJAMA Ophthalmology · 2026
2. Severe Rotisserie Tilt of Scleral-Fixated CT Lucia 602 Intraocular Lenses: A Multicenter Case SeriesOphthalmic surgery, lasers & imaging retina · 2026
3. Unveiling the tumor: a rare case of choroidal melanoma concealed by emulsified silicone oil and retinal detachmentGMS ophthalmology cases · 2026
4. Console-Associated Surgical Workflow Performance in Vitreoretinal Surgery: A Comparative Time-and-Motion Study of UNITY VCS and CONSTELLATION Vision SystemsOphthalmology and Therapy · 2026
5. Understanding the Geographic Atrophy Journey: Patient and Physician Perspectives to Inform Better CareOphthalmology and Therapy · 2026
6. A 48-Month, Prospective, Multicenter, Natural History Study of ChoroideremiaOphthalmology Science · 2026
7. Safety and efficacy of topical OCS-01 ophthalmic suspension for the treatment of diabetic macular oedema: stage 1 of a multicentre, double-blind, randomised, vehicle-controlled phase 2/3 trialEClinicalMedicine · 2026
8. Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea studyScientific Reports · 2026
9. ENRICHED trial of preservative-free lubricants in dry eye diseaseScientific Reports · 2026
10. Gildeuretinol Acetate vs Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The SAGA Randomized Clinical TrialOphthalmology Retina · 2026
11. Safety and Biological Activity of Intravitreal OGX110, a CXCR3 Agonist, in Persistent Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study2026
12. Efficacy of Continuous Pegcetacoplan Treatment for Subfoveal Geographic Atrophy in Age-Related Macular Degeneration: 36-Month Results from OAKS, DERBY, and GALE Open-Label ExtensionClinical ophthalmology · 2026
13. Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3Retina · 2026
14. Effects of Time from Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase III TrialsOphthalmology Retina · 2026
15. Gene therapy for wet AMD: a paradigm shift in the standard of careExpert Opinion on Emerging Drugs · 2026
16. Long-term Efficacy and Safety of Photobiomodulation in Dry Age-Related Macular Degeneration (LIGHTSITE III: 24-Month Analysis)Retina · 2026
17. Remote Physiologic Monitoring and Principal Care Management for Chronic Retinal Diseases: Results from over 80,000 Encounters2026
18. The Burden of Delayed Diabetic Retinopathy Management and Use of Artificial Intelligence-Driven Screening Tools: A Systematic Literature ReviewOphthalmology and Therapy · 2026
19. Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a studyBMJ Open Ophthalmology · 2026
20. Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea StudyScientific Reports · 2026